Abstract
Human spleen cells were tested for the ability to produce T cell growth factor (TCGF) upon stimulation with PHA. Quantitative analysis of the amounts of TCGF produced under optimal conditions indicated that supernatants obtained from spleen cell cultures were approximately five times more active than those derived from peripheral blood leucocytes (PBL). Moreover, in contrast to PBL, there was no significant difference in TCGF production between individual spleen cell populations. Among splenic T cells, TG-depleted cell fractions were superior to TG-enriched cell fractions in producing TCGF upon PHA stimulation. These supernatants induced intense proliferation of blast cell populations isolated from mixed leucocyte-tumour cell cultures (MLTC) established with PBL and irradiated allogeneic myelogenous leukaemic cells. Within 7 days of culture in TCGF, the number of MLTC blast cells increased approximately 300-fold. Concomitantly, the lytic activity (on a per-cell basis) of these populations against the corresponding myelogenous leukaemic cell targets increased approximately 80-fold.
MeSH Terms
Cell Survival
Cells, Cultured
Humans
Interleukin-2/metabolism
Leukemia, Myeloid/immunology
Lymphocytes/immunology
Lymphokines/metabolism
Mitosis
Phytohemagglutinins/pharmacology
Spleen/cytology,immunology
T-Lymphocytes/cytology
Thymidine/metabolism
Chemicals
Interleukin-2
Lymphokines
Phytohemagglutinins
Thymidine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Moretta A
Colombatti M
Chapuis B
References (13)
13 references, click to expand
-
Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.
J Exp Med. 1974 Sep 1;140(3):703-17
PMID: 4278108
-
Selective in vitro growth of T lymphocytes from normal human bone marrows.
Science. 1976 Sep 10;193(4257):1007-8
PMID: 181845
-
Mechanism of target cell lysis of cytolytic T lymphocytes. I. Characterization of specific lymphocyte-target cell conjugates separated by velocity sedimentation.
Eur J Immunol. 1977 Feb;7(2):110-7
PMID: 68883
-
Functional and morphologic characterization of human T cells continuously grown in vitro.
J Immunol. 1977 Jul;119(1):131-8
PMID: 141483
-
Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements.
Cryobiology. 1977 Dec;14(6):637-48
PMID: 338248
-
Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC.
J Immunol. 1978 Feb;120(2):370-7
PMID: 146052
-
Quantitation and cloning of cytolytic T lymphocytes and their precursors.
Immunol Rev. 1980;51:93-123
PMID: 6448800
-
Monoclonal cytolytic T-cell lines.
J Exp Med. 1979 Jan 1;149(1):273-8
PMID: 310861
-
Human T cell growth factor. I. Optimal conditions for its production.
J Immunol. 1979 Sep;123(3):977-83
PMID: 157374
-
Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.
J Immunol. 1979 Dec;123(6):2704-8
PMID: 315430
-
Continued growth of functional human T lymphocytes: production of human T-cell growth factor.
Cell Immunol. 1980 May;51(2):390-401
PMID: 6966190
-
In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.
J Immunol. 1980 Jun;124(6):2972-8
PMID: 6989911
-
Macrophage requirement for production of the human mitogenic factor in vitro.
Scand J Immunol. 1978;8(5):465-8
PMID: 310155